Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine




Disease hepatitis c
Symptom |liver disease
Sentences 83
PubMedID- 24130726 This study analyses the evolution of liver disease in women with chronic hepatitis c during the third trimester of pregnancy and the post-partum period, as a natural model of immune modulation and reconstitution.
PubMedID- 22797645 Effect of silymarin (milk thistle) on liver disease in patients with chronic hepatitis c unsuccessfully treated with interferon therapy: a randomized controlled trial.
PubMedID- 23213601 46-year-old female patient whose blood group was “a1 positive” underwent deceased donor liver transplantation (ddlt) from identical blood group donor for end-stage liver disease due to hepatitis c with meld score of 26. pre-operatively, she had comorbidities in the form of diabetes mellitus and recurrent hepatic hydrothorax requiring frequent therapeutic aspiration.
PubMedID- 20616580 Lipid metabolism and liver disease in hepatitis c viral infection.
PubMedID- 22970270 Eligible patients were ≥18 years of age, had compensated liver disease due to chronic hepatitis c virus (hcv) infection (any fibrosis stage, including compensated cirrhosis), detectable plasma hcv rna levels, and had received no previous treatment for hepatitis c. patients were excluded if they were co-infected with human immunodeficiency virus or hepatitis b virus or had any other cause of liver disease, severe depression or psychiatric disorder, or active substance or alcohol consumption >20 g/day in the last five years, as evaluated by a questionnaire.
PubMedID- 24815847 Chronic liver disease due to hepatitis c affects a large number of hiv-infected patients in latin america and currently poses important challenges for the health systems in the region.
PubMedID- 21258658 Hepatitis b and hepatitis c are important causes of chronic liver disease globally.
PubMedID- 22619486 Reported on 3 patients suffering from sp after liver transplantation, namely, two 42- and 62-year-old males with end-stage liver disease due to hepatitis c infection without significant other past medical or surgical history and a 59-year-old alcoholic.
PubMedID- 20517909 Timing of hepatitis c antiviral therapy in patients with advanced liver disease: a decision analysis model.
PubMedID- 26125137 Low cross-neutralization of hepatitis c correlates with liver disease in immunocompromized patients.
PubMedID- 21294867 The high proportion of patients with chronic liver disease associated with hepatitis c virus coinfection might have contributed to lessen the differences between treatment groups.
PubMedID- 25457210 Background & aims: genetic variants of patatin-like phospholipase domain-containing 3 (pnpla3) and diabetes are associated with liver disease severity, in patients with chronic hepatitis c (chc) infection.
PubMedID- 20424599 For hb, achieving safe, effective gene transfer in skeletal muscle would afford a therapeutic alternative to those patients with advanced liver disease due to hepatitis c contracted from plasma-derived coagulation concentrates.
PubMedID- 22030902 Risk for future clinical outcomes is proportional to the severity of liver disease in patients with chronic hepatitis c virus (hcv).
PubMedID- 25320839 Background: heavy alcohol use has been hypothesized to accelerate disease progression to end-stage liver disease in patients with hepatitis c virus (hcv) infection.
PubMedID- 22504920 Hepatitis b and hepatitis c infections are important causes of end-stage liver disease and primary liver cancer.
PubMedID- 24224747 We analysed data from 275 chronic hepatitis c (chc) patients with compensated liver disease who underwent 318 courses of pegifna and ribavirin.
PubMedID- 25400432 Chronic liver disease including hepatitis c virus (hcv) infection is one of the main cause for the development of hepatic angiogenesis and thereby plays a critical role in the modulation of hepatic angiogenesis that finally leads to hepatocellular carcinoma progression and invasion.
PubMedID- 21911884 Conclusion: based on our data, microsatellite variations in the hmox1 and ugt1a1 genes are not likely to protect from progression of liver disease in patients with chronic hepatitis c.
PubMedID- 25961570 Reduced expression of ifnar1 has also been observed in the liver biopsies of chronic liver disease patients with hepatitis c virus infection .
PubMedID- 20367803 liver disease due to hepatitis c virus (hcv) infection is a leading cause of non-aids-related morbidity and mortality in patients infected with hiv.
PubMedID- 25616017 Successful anti-viral treatment improves survival of patients with advanced liver disease due to chronic hepatitis c.
PubMedID- 23703797 Vitamin d is an important immune modulator that plays an emerging role in inflammatory and metabolic liver diseases, including infection with hepatitis c virus (hcv).
PubMedID- 23874824 Among the main causes of liver disease, co-infection with the hepatitis c (hcv) or hepatitis b (hbv) virus is the most frequent and has the worst prognosis 3.
PubMedID- 23226395 liver disease due to hepatitis c virus (hcv) infection is an important health problem worldwide.
PubMedID- 21145859 Role of a cirrhosis risk score for the early prediction of fibrosis progression in hepatitis c patients with minimal liver disease.
PubMedID- 20617177 Chronic hepatitis c is associated with severe liver disease including hepatitis, liver cirrhosis and hepatocellular carcinoma and it is the most frequent indication for liver transplantation 4.
PubMedID- 21645344 In this article we discuss several liver conditions which are directly affected by overweight and obese status, including non-alcoholic fatty liver disease, chronic infection with hepatitis c virus and post-liver transplant status.
PubMedID- 24695489 End stage liver disease associated with hepatitis c virus infection constitutes one of the principal indications for liver transplant.
PubMedID- 25088088 Background and aim: assessment of the severity of liver disease following infection with hepatitis c virus (hcv) is important in treatment selection and prognosis.
PubMedID- 25339354 The 13c-galactose bt has also been used to assess progressive decline in liver mass function in patients with chronic liver disease due to hepatitis c virus (hcv) infection .
PubMedID- 23630437 Status of essential trace minerals and oxidative stress in viral hepatitis c patients with nonalcoholic fatty liver disease.
PubMedID- 21849046 In one of the studies, mmp-9 levels were negatively correlated to the histological severity of the liver disease in patients with chronic hepatitis c .

Page: 1 2